Status:
COMPLETED
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
Lead Sponsor:
POZEN
Conditions:
Bunionectomy
Orthopedic Surgery
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower ext...
Eligibility Criteria
Inclusion
- Subjects who are scheduled for a primary unilateral first metatarsal bunionectomy under local anesthetic.
- Subjects have no contraindications to this surgery and have no allergies to the study medications or similar medications.
- Subjects are in generally good health with no uncontrolled chronic illnesses or diseases.
Exclusion
- Subjects who are pregnant.
- Subjects who have significant obesity.
- Subjects with medically significant heart, liver, kidney, lung or endocrine disease.
- Subjects with active viral disease, i.e. hepatitis, HIV.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
March 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00293631
Start Date
November 1 2005
End Date
March 1 2006
Last Update
December 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Advanced Clinical Research Institute
Anaheim, California, United States, 92801